The DNA Synthesis Market size was estimated USD 3.46 billion in 2023 and is expected to reach USD 14.54 billion by 2031 at a CAGR of 19.62% during the forecast period of 2024-2031.
The natural formation of nucleic acid strands by DNA replication is known as DNA synthesis. They are created artificially in the laboratory utilizing genetic engineering and enzyme chemistry for a variety of purposes including therapeutics, diagnostics, and academic and industrial research. With the recent acceptance of DNA synthesis, several applications have grown in popularity.
Get more information on DNA Synthesis Market - Request Free Sample Report
DRIVERS
Increasing usage in food and the agriculture industry
Increasing demand for DNA sequences and synthetic genes
The need for synthetic genes and DNA sequences has been fast expanding due to advances in synthetic biology and genetic engineering. Synthetic genes and DNA sequences can be utilized to make novel enzymes, proteins, and other compounds with unique features for use in a variety of applications. Furthermore, developments in DNA synthesis technology have made it easier and less expensive to create genes and DNA sequences. As a result, demand for synthetic genes and DNA sequences has increased, while the cost of DNA synthesis has decreased. These synthetic genes and DNA sequences have a wide range of uses, including gene therapy, medication development, and agricultural biotechnology. For example, Evonetix describes DNA synthesizer technology that will accelerate development across many therapeutic modalities.
RESTRAIN
Synthesis Errors and Quality Control
The process of DNA synthesis is not error-free, and errors may occur. Because of these flaws, DNA sequences that differ from the planned design are produced, resulting in inaccuracies in the final output. Maintaining high-quality control requirements and reducing synthesis errors are continuous challenges for DNA synthesis businesses. Accurate synthesis is required, especially for applications such as gene therapy or DNA-based diagnostics. DNA sequencing is used by manufacturers to ensure the accuracy of manufactured DNA sequences. This entails comparing the synthesized sequence to the intended design in order to find any differences. The amount of DNA produced is measured using several techniques such as UV spectroscopy or quantitative PCR (qPCR). This guarantees that the correct amount of DNA is produced.
OPPORTUNITY
Increasing demand for personalized medicine
DNA synthesis aids in the development of potentially life-saving medications. Personalized medicine is a drug that is tailored to a patient's individual therapeutic needs. It is based on data from pharmacogenomics, pharmacogenetics, pharmacometabolomics, and pharmacoproteomics. It aids in the early detection and prevention of many ailments, as well as the monitoring of therapy. Personalized medicine is also characterized as enhanced healthcare through the use of preventative medicine, rational medication development, therapeutic monitoring, and early illness identification. Scientists are developing individualized medication for patients with specific genetic variants and mutations by employing gene synthesis. The development of DNA-based diagnostic assays relies heavily on DNA synthesis. Synthetic DNA probes or primers are used in these assays to detect specific genetic sequences linked to diseases, infections, or genetic variants. The growing desire for personalized treatment and precise diagnostics has fueled the expansion of DNA-based diagnostics.
CHALLENGES
DNA synthesis can be an expensive operation, making it difficult for researchers on tight budgets to obtain the technology.
Possibility of unintentional release of synthetic DNA or the emergence of harmful diseases
In terms of the global pharmaceutical business, the war's influence has been limited to pharma manufacturers' investments and operations, as well as exporters' market interests in Russia, Ukraine, and other CIS nations, a phenomena that may be short-term and ephemeral. This is also because Russia and Ukraine are primarily pharma importing countries, implying that global pharma is not overly reliant on this region for essential raw materials and supplies. Indeed, some major pharmaceutical corporations have reduced their activities in Russia. However, there is merit to the notion that the pharmaceutical sector is dependent on oil and gas not just for transportation and logistics, but also because a huge number of pharmaceutical goods are derived from petrochemicals.
IMPACT OF ONGOING RECESSION
Many biopharmaceutical and biotechnology companies are now scrutinizing their spending and risk. Economic realities such as uncontrollable inflation, restricted capital, and supply chain challenges may hinder expansion goals, but there are reasons for optimism, as biotech experts recently emphasized. The research has shown that recessions can have an impact on medication demand for a variety of reasons, including lower use of patented biologics and branded pharmaceuticals, as well as an increase in utilization of biosimilars and generics.
By Service Type
Oligonucleotide Synthesis
Gene Synthesis
In 2023, Oligonucleotide Synthesis segment is expected to held the highest market share of 55.2% during the forecast period owing to oligonucleotide synthesis is a rapid and low-cost method of synthesizing desired oligonucleotide sequences. Furthermore, companies are embarking on strategic endeavors to introduce unique products, which will grow the segment. For example, in October 2022, Bachem announced a collaboration with Eli-Lilly and Company for the research and manufacturing of oligonucleotide-based APIs. The collaboration calls for Bachem to provide technical infrastructure and experience to help Lilly implement its new oligonucleotide manufacturing technique.
By Application
Research and Development
Diagnostics
Therapeutics
In 2023, the Research and Development segment is expected to dominate the market growth of 24.3% during the forecast period due to the technology, there are numerous benefits, such as speedy amplification, the requirement for a small amount of material, and utility in the detection of various diseases. When compared to other traditional methods, PCR allows for higher levels of amplification of specific sequences and more sensitive detection in less time, the technique is therefore particularly valuable for forensics, genetic identification testing, in vitro diagnostics, and industrial quality control. In clinical laboratories, real-time PCR has several advantages, including the simultaneous detection of several genes, lower reagent costs, the capacity to provide internal controls, and sample preservation for tumor profiling.
By End User
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
In 2023, the Biopharmaceutical Companies segment is expected to dominate the market growth of 40.1% during the forecast period to due to increasing demand for biotechnology-based trade opportunities globally. Furthermore, synthetic nucleotides hasten the creation of enhanced bio-molecular therapeutics such as enzymes, peptides, RNA catalysts, and aptamers. Furthermore, because to advancements in nucleotide manufacturing processes and an emphasis on automation and autonomous technologies, businesses can now synthesis DNA fragments more quickly, inexpensively, and effectively. DNA synthesis is a fundamental molecular biology procedure that is important in a variety of domains, including genetic engineering and clinical diagnosis and treatment. Such elements are projected to dominate the segment.
North America held a significant market share of over 40.1% in 2023 due to the demand for synthetic nucleotides in this region is growing due to the various research projects in the region for emerging developments in biotechnology, including the rapid creation of medicines and vaccines, demand for synthetic nucleotides in this region is increasing.
Asia-Pacific is witness to expand fastest CAGR rate during the forecast period due to increased financing for biological research and drug development is increasing demand for a steady supply of synthetic nucleotides for use in research. Numerous ongoing research investigations at research institutions around the region, as well as emerging market participants, are positively impacting market growth.
REGIONAL COVERAGE
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
The major key players are GenScript Biotech Corporation, Thermo Fisher Scientific, Inc., Bioneer Corporation,Twist Bioscience, Eton Bioscience, IBA GmbH, LGC Biosearch Technologies, Eurofins Scientific, Quintara Biosciences Inc.,Integrated DNA Technologies and Others.
GenScript Biotech Corporation, in May 2023, GenScript Biotech Corporation created the GenTitan Gene Fragments Synthesis service to accelerate gene synthesis and reduce costs. This will allow the organization to broaden its service offerings and cater to a bigger consumer base.
Twist Bioscience, in January 2023, Twist Bioscience and Astellas have formed a research agreement to develop multitarget antibodies. The goal of this strategic alliance was to find antibodies against several targets of interest as well as curative medicines for individuals suffering from diseases with no therapeutic choices. This strategy is likely to assist the organization in improving its service offerings.
| Report Attributes | Details |
| Market Size in 2023 | US$ 3.46 Billion |
| Market Size by 2031 | US$ 14.54 Billion |
| CAGR | CAGR of 19.62% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Service Type (Oligonucleotide Synthesis, Gene Synthesis) • By Application (Research and Development, Diagnostics, Therapeutics) • By End User (Biopharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | GenScript Biotech Corporation, Thermo Fisher Scientific, Inc., Bioneer Corporation,Twist Bioscience, Eton Bioscience, IBA GmbH, LGC Biosearch Technologies, Eurofins Scientific, Quintara Biosciences Inc.,Integrated DNA Technologies |
| Key Drivers | • Increasing usage in food and the agriculture industry • Increasing demand for DNA sequences and synthetic genes |
| Market Challenges | • DNA synthesis can be an expensive operation, making it difficult for researchers on tight budgets to obtain the technology. • Possibility of unintentional release of synthetic DNA or the emergence of harmful diseases |
Ans: Analytical Instrumentation Market size was valued at USD 3.46 billion in 2023.
Ans: DNA Synthesis Market is anticipated to expand by 19.62% from 2024 to 2031.
Ans: North America held a significant market share of around 45.8% in 2023.
Ans: USD 14.54 billion is expected to grow by 2031.
Ans: Risk of accidental release of synthetic DNA or the creation of dangerous pathogens.
TABLE OF CONTENTS
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Industry Flowchart
3. Research Methodology
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
5. Impact Analysis
5.1 Impact of Russia-Ukraine Crisis
5.2 Impact of Economic Slowdown on Major Countries
5.2.1 Introduction
5.2.2 United States
5.2.3 Canada
5.2.4 Germany
5.2.5 France
5.2.6 UK
5.2.7 China
5.2.8 Japan
5.2.9 South Korea
5.2.10 India
6. Value Chain Analysis
7. Porter’s 5 Forces Model
8. Pest Analysis
9. DNA Synthesis Market Segmentation, By Service Type
9.1 Introduction
9.3 Oligonucleotide Synthesis
9.4 Gene Synthesis
10. DNA Synthesis Market Segmentation, By Application
10.2 Trend Analysis
10.3 Research and Development
10.4 Diagnostics
10.5 Therapeutics
11. DNA Synthesis Market Segmentation, By End user
11.1 Introduction
11.3 Biopharmaceutical Companies
11.4 Academic and Research Institutes
11.5 Contract Research Organizations
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 Trend Analysis
12.2.2 North America DNA Synthesis Market by Country
12.2.3 North America DNA Synthesis Market By Service Type
12.2.4 North America DNA Synthesis Market By Application
12.2.5 North America DNA Synthesis Market By End user
12.2.6 USA
12.2.6.1 USA DNA Synthesis Market By Service Type
12.2.6.2 USA DNA Synthesis Market By Application
12.2.6.3 USA DNA Synthesis Market By End user
12.2.7 Canada
12.2.7.1 Canada DNA Synthesis Market By Service Type
12.2.7.2 Canada DNA Synthesis Market By Application
12.2.7.3 Canada DNA Synthesis Market By End user
12.2.8 Mexico
12.2.8.1 Mexico DNA Synthesis Market By Service Type
12.2.8.2 Mexico DNA Synthesis Market By Application
12.2.8.3 Mexico DNA Synthesis Market By End user
12.3 Europe
12.3.1 Trend Analysis
12.3.2 Eastern Europe
12.3.2.1 Eastern Europe DNA Synthesis Market by Country
12.3.2.2 Eastern Europe DNA Synthesis Market By Service Type
12.3.2.3 Eastern Europe DNA Synthesis Market By Application
12.3.2.4 Eastern Europe DNA Synthesis Market By End user
12.3.2.5 Poland
12.3.2.5.1 Poland DNA Synthesis Market By Service Type
12.3.2.5.2 Poland DNA Synthesis Market By Application
12.3.2.5.3 Poland DNA Synthesis Market By End user
12.3.2.6 Romania
12.3.2.6.1 Romania DNA Synthesis Market By Service Type
12.3.2.6.2 Romania DNA Synthesis Market By Application
12.3.2.6.4 Romania DNA Synthesis Market By End user
12.3.2.7 Hungary
12.3.2.7.1 Hungary DNA Synthesis Market By Service Type
12.3.2.7.2 Hungary DNA Synthesis Market By Application
12.3.2.7.3 Hungary DNA Synthesis Market By End user
12.3.2.8 Turkey
12.3.2.8.1 Turkey DNA Synthesis Market By Service Type
12.3.2.8.2 Turkey DNA Synthesis Market By Application
12.3.2.8.3 Turkey DNA Synthesis Market By End user
12.3.2.9 Rest of Eastern Europe
12.3.2.9.1 Rest of Eastern Europe DNA Synthesis Market By Service Type
12.3.2.9.2 Rest of Eastern Europe DNA Synthesis Market By Application
12.3.2.9.3 Rest of Eastern Europe DNA Synthesis Market By End user
12.3.3 Western Europe
12.3.3.1 Western Europe DNA Synthesis Market by Country
12.3.3.2 Western Europe DNA Synthesis Market By Service Type
12.3.3.3 Western Europe DNA Synthesis Market By Application
12.3.3.4 Western Europe DNA Synthesis Market By End user
12.3.3.5 Germany
12.3.3.5.1 Germany DNA Synthesis Market By Service Type
12.3.3.5.2 Germany DNA Synthesis Market By Application
12.3.3.5.3 Germany DNA Synthesis Market By End user
12.3.3.6 France
12.3.3.6.1 France DNA Synthesis Market By Service Type
12.3.3.6.2 France DNA Synthesis Market By Application
12.3.3.6.3 France DNA Synthesis Market By End user
12.3.3.7 UK
12.3.3.7.1 UK DNA Synthesis Market By Service Type
12.3.3.7.2 UK DNA Synthesis Market By Application
12.3.3.7.3 UK DNA Synthesis Market By End user
12.3.3.8 Italy
12.3.3.8.1 Italy DNA Synthesis Market By Service Type
12.3.3.8.2 Italy DNA Synthesis Market By Application
12.3.3.8.3 Italy DNA Synthesis Market By End user
12.3.3.9 Spain
12.3.3.9.1 Spain DNA Synthesis Market By Service Type
12.3.3.9.2 Spain DNA Synthesis Market By Application
12.3.3.9.3 Spain DNA Synthesis Market By End user
12.3.3.10 Netherlands
12.3.3.10.1 Netherlands DNA Synthesis Market By Service Type
12.3.3.10.2 Netherlands DNA Synthesis Market By Application
12.3.3.10.3 Netherlands DNA Synthesis Market By End user
12.3.3.11 Switzerland
12.3.3.11.1 Switzerland DNA Synthesis Market By Service Type
12.3.3.11.2 Switzerland DNA Synthesis Market By Application
12.3.3.11.3 Switzerland DNA Synthesis Market By End user
12.3.3.1.12 Austria
12.3.3.12.1 Austria DNA Synthesis Market By Service Type
12.3.3.12.2 Austria DNA Synthesis Market By Application
12.3.3.12.3 Austria DNA Synthesis Market By End user
12.3.3.13 Rest of Western Europe
12.3.3.13.1 Rest of Western Europe DNA Synthesis Market By Service Type
12.3.3.13.2 Rest of Western Europe DNA Synthesis Market By Application
12.3.3.13.3 Rest of Western Europe DNA Synthesis Market By End user
12.4 Asia-Pacific
12.4.1 Trend Analysis
12.4.2 Asia-Pacific DNA Synthesis Market by Country
12.4.3 Asia-Pacific DNA Synthesis Market By Service Type
12.4.4 Asia-Pacific DNA Synthesis Market By Application
12.4.5 Asia-Pacific DNA Synthesis Market By End user
12.4.6 China
12.4.6.1 China DNA Synthesis Market By Service Type
12.4.6.2 China DNA Synthesis Market By Application
12.4.6.3 China DNA Synthesis Market By End user
12.4.7 India
12.4.7.1 India DNA Synthesis Market By Service Type
12.4.7.2 India DNA Synthesis Market By Application
12.4.7.3 India DNA Synthesis Market By End user
12.4.8 Japan
12.4.8.1 Japan DNA Synthesis Market By Service Type
12.4.8.2 Japan DNA Synthesis Market By Application
12.4.8.3 Japan DNA Synthesis Market By End user
12.4.9 South Korea
12.4.9.1 South Korea DNA Synthesis Market By Service Type
12.4.9.2 South Korea DNA Synthesis Market By Application
12.4.9.3 South Korea DNA Synthesis Market By End user
12.4.10 Vietnam
12.4.10.1 Vietnam DNA Synthesis Market By Service Type
12.4.10.2 Vietnam DNA Synthesis Market By Application
12.4.10.3 Vietnam DNA Synthesis Market By End user
12.4.11 Singapore
12.4.11.1 Singapore DNA Synthesis Market By Service Type
12.4.11.2 Singapore DNA Synthesis Market By Application
12.4.11.3 Singapore DNA Synthesis Market By End user
12.4.12 Australia
12.4.12.1 Australia DNA Synthesis Market By Service Type
12.4.12.2 Australia DNA Synthesis Market By Application
12.4.12.3 Australia DNA Synthesis Market By End user
12.4.13 Rest of Asia-Pacific
12.4.13.1 Rest of Asia-Pacific DNA Synthesis Market By Service Type
12.4.13.2 Rest of Asia-Pacific DNA Synthesis Market By Application
12.4.13.3 Rest of Asia-Pacific DNA Synthesis Market By End user
12.5 Middle East & Africa
12.5.1 Trend Analysis
12.5.2 Middle East
12.5.2.1 Middle East DNA Synthesis Market by Country
12.5.2.2 Middle East DNA Synthesis Market By Service Type
12.5.2.3 Middle East DNA Synthesis Market By Application
12.5.2.4 Middle East DNA Synthesis Market By End user
12.5.2.5 UAE
12.5.2.5.1 UAE DNA Synthesis Market By Service Type
12.5.2.5.2 UAE DNA Synthesis Market By Application
12.5.2.5.3 UAE DNA Synthesis Market By End user
12.5.2.6 Egypt
12.5.2.6.1 Egypt DNA Synthesis Market By Service Type
12.5.2.6.2 Egypt DNA Synthesis Market By Application
12.5.2.6.3 Egypt DNA Synthesis Market By End user
12.5.2.7 Saudi Arabia
12.5.2.7.1 Saudi Arabia DNA Synthesis Market By Service Type
12.5.2.7.2 Saudi Arabia DNA Synthesis Market By Application
12.5.2.7.3 Saudi Arabia DNA Synthesis Market By End user
12.5.2.8 Qatar
12.5.2.8.1 Qatar DNA Synthesis Market By Service Type
12.5.2.8.2 Qatar DNA Synthesis Market By Application
12.5.2.8.3 Qatar DNA Synthesis Market By End user
12.5.2.9 Rest of Middle East
12.5.2.9.1 Rest of Middle East DNA Synthesis Market By Service Type
12.5.2.9.2 Rest of Middle East DNA Synthesis Market By Application
12.5.2.9.3 Rest of Middle East DNA Synthesis Market By End user
12.5.3 Africa
12.5.3.1 Africa DNA Synthesis Market by Country
12.5.3.2 Africa DNA Synthesis Market By Service Type
12.5.3.3 Africa DNA Synthesis Market By Application
12.5.3.4 Africa DNA Synthesis Market By End user
12.5.3.5 Nigeria
12.5.3.5.1 Nigeria DNA Synthesis Market By Service Type
12.5.3.5.2 Nigeria DNA Synthesis Market By Application
12.5.3.5.3 Nigeria DNA Synthesis Market By End user
12.5.3.6 South Africa
12.5.3.6.1 South Africa DNA Synthesis Market By Service Type
12.5.3.6.2 South Africa DNA Synthesis Market By Application
12.5.3.6.3 South Africa DNA Synthesis Market By End user
12.5.3.7 Rest of Africa
12.5.3.7.1 Rest of Africa DNA Synthesis Market By Service Type
12.5.3.7.2 Rest of Africa DNA Synthesis Market By Application
12.5.3.7.3 Rest of Africa DNA Synthesis Market By End user
12.6 Latin America
12.6.1 Trend Analysis
12.6.2 Latin America DNA Synthesis Market by country
12.6.3 Latin America DNA Synthesis Market By Service Type
12.6.4 Latin America DNA Synthesis Market By Application
12.6.5 Latin America DNA Synthesis Market By End user
12.6.6 Brazil
12.6.6.1 Brazil DNA Synthesis Market By Service Type
12.6.6.2 Brazil DNA Synthesis Market By Application
12.6.6.3 Brazil DNA Synthesis Market By End user
12.6.7 Argentina
12.6.7.1 Argentina DNA Synthesis Market By Service Type
12.6.7.2 Argentina DNA Synthesis Market By Application
12.6.7.3 Argentina DNA Synthesis Market By End user
12.6.8 Colombia
12.6.8.1 Colombia DNA Synthesis Market By Service Type
12.6.8.2 Colombia DNA Synthesis Market By Application
12.6.8.3 Colombia DNA Synthesis Market By End user
12.6.9 Rest of Latin America
12.6.9.1 Rest of Latin America DNA Synthesis Market By Service Type
12.6.9.2 Rest of Latin America DNA Synthesis Market By Application
12.6.9.3 Rest of Latin America DNA Synthesis Market By End user
13. Company Profiles
13.1 GenScript Biotech Corporation
13.1.1 Company Overview
13.1.2 Financial
13.1.3 Service Type/ Services Offered
13.1.4 SWOT Analysis
13.1.5 The SNS View
13.2 Thermo Fisher Scientific, Inc.
13.2.1 Company Overview
13.2.2 Financial
13.2.3 Service Type / Services Offered
13.2.4 SWOT Analysis
13.2.5 The SNS View
13.3 Bioneer Corporation
13.3.1 Company Overview
13.3.2 Financial
13.3.3 Service Type / Services Offered
13.3.4 SWOT Analysis
13.3.5 The SNS View
13.4 Twist Bioscience
13.4.1 Company Overview
13.4.2 Financial
13.4.3 Service Type / Services Offered
13.4.4 SWOT Analysis
13.4.5 The SNS View
13.5 Eton Bioscience
13.5.1 Company Overview
13.5.2 Financial
13.5.3 Service Type/ Services Offered
13.5.4 SWOT Analysis
13.5.5 The SNS View
13.6 IBA GmbH
13.6.1 Company Overview
13.6.2 Financial
13.6.3 Service Type/ Services Offered
13.6.4 SWOT Analysis
13.6.5 The SNS View
13.7 LGC Biosearch Technologies
13.7.1 Company Overview
13.7.2 Financial
13.7.3 Service Type/ Services Offered
13.7.4 SWOT Analysis
13.7.5 The SNS View
13.8.1 Company Overview
13.8.2 Financial
13.8.3 Service Type/ Services Offered
13.8.4 SWOT Analysis
13.8.5 The SNS View
13.9 Quintara Biosciences Inc.
13.9.1 Company Overview
13.9.2 Financial
13.9.3 Service Type/ Services Offered
13.9.4 SWOT Analysis
13.9.5 The SNS View
13.10 Integrated DNA Technologies
13.10.1 Company Overview
13.10.2 Financial
13.10.3 Service Type/ Services Offered
13.10.4 SWOT Analysis
13.10.5 The SNS View
14. Competitive Landscape
14.1 Competitive Benchmarking
14.2 Market Share Analysis
14.3 Recent Developments
14.3.1 Industry News
14.3.2 Company News
14.3.3 Mergers & Acquisitions
15. Use Case and Best Practices
16. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Artificial Intelligence in Ultrasound Imaging Market size was valued at $934.99 Mn in 2023 and is expected to reach $1825 Mn by 2031 and grow at a CAGR of 8.65% over the global forecast period of 2024-2031.
In 2023, The Diabetic Ulcer Treatment Market size amounted to USD 10.31 Billion & is estimated to reach USD 15.59 Billion by 2031 and increase at a compound annual growth rate of 5.3% between 2024 and 2031.
The Analgesics Market was esteemed at USD 29.44 billion out of 2022, and expected to arrive at USD 48 billion by 2030, and develop at a CAGR of 6.3% over the conjecture period 2023-2030.
The Dental Regeneration Market size was estimated USD 6.0 billion in 2022 and is expected to reach USD 8.9 billion by 2030 at a CAGR of 5.1% during the forecast period of 2023-2030.
The Cardiovascular Information System Market Size was valued at USD 1.31 billion in 2023 and is expected to reach USD 2.68 billion by 2031, and grow at a CAGR of 9.4% over the forecast period 2024-2031.
The 3D printed wearables market is valued at USD 3.96 billion in 2022, and it is estimated to increase at a CAGR of 9.7% from 2022 to 2028, reaching USD 8.30 billion by 2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
